Equity Investment Corp’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Equity Investment Corp’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,780	Closed	-$469K	–	61
2017 Q4	$469K	Buy	+10,780	New	+$458K	0.02%	46

Other funds holding XPH

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Arnhold LLC New York $1.36B AUM 53.52% 1-Year Est. Return

Equity Investment Corp's XPH Position: Q1 2018 in Review

Equity Investment Corp sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2018, closing a stake of 10,780 shares — an estimated $469K sold.

Equity Investment Corp first reported a position in XPH in Q4 2017 and held it in 1 quarter. The position peaked at $469K in Q4 2017. 75 funds tracked by Wall St. Rank hold XPH as of Q1 2018.

Equity Investment Corp reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
Equity Investment Corp sold 10,780 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2018, an estimated $469K.
Equity Investment Corp first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2017 and held it in 1 quarter.
Equity Investment Corp's State Street SPDR S&P Pharmaceuticals ETF position peaked at $469K in Q4 2017.
75 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2018.

Based on Equity Investment Corp's 13F filing for Q1 2018, filed 7 May 2018.